ArticleClinical pharmacokinetics2025

Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma.

Theodoros Papathanasiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.